Martres M P, Sokoloff P, Delandre M, Schwartz J C, Protais P, Costentin J
Naunyn Schmiedebergs Arch Pharmacol. 1984 Feb;325(2):102-15. doi: 10.1007/BF00506189.
In order to document the hypothesis that antipsychotics may interact with more than one class of cerebral dopamine receptors, the relative potencies of a series of compounds were compared in three behavioral tests and in binding studies with two radioligands. Apomorphine (0.6 mg/kg) simultaneously elicited in rat two kinds of facial stereotypies (sniffing and licking) and a stereotyped climbing behavior, allowing to compare in the same animals the relative potencies of various antipsychotics against the three behaviors. Only some substituted benzamides (Sulpiride, LUR 2366 and DAN 2163) antagonised at significantly lower dosages climbing than sniffing (or licking). The possibility that this discriminant potency might be related to a distinct affinity for two classes of dopamine receptors was investigated by binding studies on striatal membranes with 3H-apomorphine and 3H-domperidone. From lesion and subcellular fractionation studies, two classes of binding sites both labeled with 3H-domperidone but distinguished by apomorphine i.e. D-2 sites with nM affinity and D-4 sites with microM affinity for the dopamine agonist (according to the nomenclature of Sokoloff et al. 1980 b) appear to be differently localised in striatum. Thus D-2 sites, whose number decreases after kainate lesion, are not significantly modified following cortical lesions and preferentially sediment with heavy primary subcellular fractions. In contrast D-4 sites, less affected by kainate lesions, are significantly decreased following cortical lesions (-30%) and preferentially sediment with the light subcellular fractions. In addition the apparently heterogeneous recognition of total 3H-domperidone binding sites (i.e. the sum of D-2 and D-4 sites) by dopamine and apomorphine persists in the presence of guanosine-5'-triphosphate (pseudo-Hill coefficient of 0.60 instead of 0.55). This suggests that D-2 and D-4 sites cannot be considered as two discrete states of the same receptor strictly convertible one into the other by guanylnucleotides. Whereas most dopamine antagonists inhibited D-2 and D-4 site binding with similar affinities, the three benzamide derivatives with the largest selectivity in behavioral tests displayed 2-3-fold higher affinity for D-4 than for D-2 sites and the ratios of ID50 values of the whole series of antagonists against sniffing (or licking) and climbing behaviors were correlated (P less than 0.01) with the ratios of Ki values regarding D-2 and D-4 site binding. Also, sulpiride and LUR 2366 unlike haloperidol and metoclopramide, inhibited the total specific 3H-domperidone binding in a biphasic manner.(ABSTRACT TRUNCATED AT 400 WORDS)
为了验证抗精神病药物可能与不止一类脑多巴胺受体相互作用这一假说,在三项行为测试以及与两种放射性配体的结合研究中比较了一系列化合物的相对效价。阿扑吗啡(0.6毫克/千克)能同时在大鼠中引发两种面部刻板行为(嗅舔)和一种刻板攀爬行为,从而可以在同一动物中比较各种抗精神病药物针对这三种行为的相对效价。只有一些取代苯甲酰胺(舒必利、LUR 2366和DAN 2163)在显著更低剂量下对攀爬行为的拮抗作用比对嗅舔行为的更强。通过用3H-阿扑吗啡和3H-多潘立酮对纹状体膜进行结合研究,探讨了这种区分性效价可能与对两类多巴胺受体的不同亲和力相关的可能性。从损伤和亚细胞分级分离研究来看,两类结合位点都能用3H-多潘立酮标记,但可被阿扑吗啡区分,即对多巴胺激动剂具有纳摩尔亲和力的D-2位点和具有微摩尔亲和力的D-4位点(根据索科洛夫等人1980年b的命名法)在纹状体中的定位似乎不同。因此,D-2位点的数量在 kainate损伤后减少,在皮质损伤后无显著变化,并且优先沉淀在重的初级亚细胞组分中。相比之下,D-4位点受kainate损伤的影响较小,在皮质损伤后显著减少(-30%),并且优先沉淀在轻的亚细胞组分中。此外,在存在鸟苷-5'-三磷酸的情况下,多巴胺和阿扑吗啡对总3H-多潘立酮结合位点(即D-2和D-4位点之和)的明显异质性识别仍然存在(伪希尔系数为0.60而非0.55)。这表明D-2和D-4位点不能被视为同一受体的两种严格可通过鸟苷酸相互转换的离散状态。虽然大多数多巴胺拮抗剂以相似亲和力抑制D-2和D-4位点结合,但在行为测试中具有最大选择性的三种苯甲酰胺衍生物对D-4位点的亲和力比对D-2位点高2 - 3倍,并且整个系列拮抗剂针对嗅舔(或舔舐)和攀爬行为的ID50值之比与关于D-2和D-4位点结合的Ki值之比相关(P小于0.01)。此外,与氟哌啶醇和甲氧氯普胺不同,舒必利和LUR 2366以双相方式抑制总特异性3H-多潘立酮结合。(摘要截于400字)